{"formats":[{"name":"JSON","format":"json","url":"\/downloads\/2025\/code-json\/22.1-274.2.json"},{"name":"Plain Text","format":"text","url":"\/downloads\/2025\/code-text\/22.1-274.2.txt"},{"name":"XML","format":"xml","url":"\/downloads\/2025\/code-xml\/22.1-274.2.xml"},{"name":"HTML","format":"html","url":"\/downloads\/2025\/code-html\/22.1-274.2.html"}],"law_id":78246,"edition_id":1,"section_id":78246,"structure_id":13512,"section_number":"22.1-274.2","catch_line":"Possession and administration of inhaled asthma medications, epinephrine, glucagon, and seizure rescue medications by certain students or school board employees","history":"2000, c. 871; 2005, c. 785; 2012, cc. 787, 833; 2013, cc. 336, 617; 2020, c. 476; 2021, Sp. Sess. I, c. 508; 2023, cc. 183, 569; 2024, c. 466; 2025, cc. 59, 65.","full_text":"A\n\nLocal school boards shall develop and implement policies permitting a student with a diagnosis of asthma or anaphylaxis, or both, to possess and self-administer inhaled asthma medications or auto-injectable epinephrine, or both, as the case may be, during the school day, at school-sponsored activities, or while on a school bus or other school property. Such policies shall include, but not be limited to, provisions for:1\n\nWritten consent of the parent, as defined in § 22.1-1, of a student with a diagnosis of asthma or anaphylaxis, or both, that the student may self-administer inhaled asthma medications or auto-injectable epinephrine, or both, as the case may be.2\n\nWritten notice from the student’s primary care provider or medical specialist, or a licensed physician or licensed advanced practice registered nurse, that (i) identifies the student; (ii) states that the student has a diagnosis of asthma or anaphylaxis, or both, and has approval to self-administer inhaled asthma medications or auto-injectable epinephrine, or both, as the case may be, that have been prescribed or authorized for the student; (iii) specifies the name and dosage of the medication, the frequency in which it is to be administered and certain circumstances which may warrant the use of inhaled asthma medications or auto-injectable epinephrine, such as before exercising or engaging in physical activity to prevent the onset of asthma symptoms or to alleviate asthma symptoms after the onset of an asthma episode; and (iv) attests to the student’s demonstrated ability to safely and effectively self-administer inhaled asthma medications or auto-injectable epinephrine, or both, as the case may be.3\n\nDevelopment of an individualized health care plan, including emergency procedures for any life-threatening conditions.4\n\nConsultation with the student’s parent before any limitations or restrictions are imposed upon a student’s possession and self-administration of inhaled asthma medications and auto-injectable epinephrine, and before the permission to possess and self-administer inhaled asthma medications and auto-injectable epinephrine at any point during the school year is revoked.5\n\nSelf-administration of inhaled asthma medications and auto-injectable epinephrine to be consistent with the purposes of the Virginia School Health Guidelines and the Guidelines for Specialized Health Care Procedure Manuals, which are jointly issued by the Department of Education and the Department of Health.6\n\nDisclosure or dissemination of information pertaining to the health condition of a student to school board employees to comply with §§ 22.1-287 and 22.1-289 and the federal Family Education Rights and Privacy Act of 1974, as amended, 20 U.S.C. § 1232g, which govern the disclosure and dissemination of information contained in student scholastic records.B\n\nThe permission granted a student with a diagnosis of asthma or anaphylaxis, or both, to possess and self-administer inhaled asthma medications or auto-injectable epinephrine, or both, shall be effective for one school year. Permission to possess and self-administer such medications shall be renewed annually. For the purposes of this section, “one school year” means 365 calendar days.C\n\nLocal school boards shall adopt and implement policies for the possession and administration of epinephrine in every school, to be administered by any school nurse, employee of the school board, employee of a local governing body, or employee of a local health department who is authorized by a prescriber and trained in the administration of epinephrine to any student believed to be having an anaphylactic reaction. Such policies shall require that at least one school nurse, employee of the school board, employee of a local governing body, or employee of a local health department who is authorized by a prescriber and trained in the administration of epinephrine has the means to access at all times during regular school hours any such epinephrine that is stored in a locked or otherwise generally inaccessible container or area.D\n\nEach local school board shall adopt and implement policies for the possession and administration of undesignated stock albuterol inhalers and valved holding chambers in every public school in the local school division, to be administered by any school nurse, licensed athletic trainer under contract with a local school division, employee of the school board, employee of a local governing body, or employee of a local health department who is authorized by the local health director and trained in the administration of albuterol inhalers and valved holding chambers for any student believed in good faith to be in need of such medication.E\n\nAny local school board may adopt and implement policies for the possession and administration of undesignated nasal or injectable glucagon in each public elementary or secondary school in the local school division, provided that such policies are consistent with the guidance outlined in the most recent revision of the Diabetes Management In School: Manual for Unlicensed Personnel published by the Department and include guidance outlining the following:1\n\nOne or more locations in each public elementary or secondary school in the local school division in which doses of such undesignated glucagon shall be stored;2\n\nThe conditions under which doses of such undesignated glucagon shall be stored, replaced, and disposed;3\n\nThe individuals who are authorized to access and administer doses of such undesignated glucagon in an emergency and training requirements for such individuals; and4\n\nA process for requesting emergency medical services and notifying appropriate personnel immediately after a dose of such undesignated glucagon is administered.F\n\nAny public elementary or secondary school may maintain a supply of nasal or injectable glucagon in any secure location that is immediately accessible to any school nurse or other employee trained in the administration of nasal and injectable glucagon prescribed to the school by a prescriber, as defined in § 54.1-3401. Any such school shall ensure that such a supply consists of at least two doses. Any school nurse or other authorized employee who is trained in the administration of nasal and injectable glucagon consistent with the guidance outlined in the most recent revision of the Diabetes Management In School: Manual for Unlicensed Personnel published by the Department may administer nasal or injectable glucagon from undesignated inventory with parental consent and if the student’s prescribed glucagon is not available on school grounds or has expired.G\n\nAny school board may accept donations of nasal or injectable glucagon from a wholesale distributor of glucagon or donations of money from any individual to purchase nasal or injectable glucagon for the purpose of maintenance and administration in a public school in the local school division as permitted pursuant to subsection F.H\n\nAny school board may adopt and implement policies:1\n\nPermitting any student enrolled in any secondary school in the local school division who has a diagnosis of a condition causing seizures to possess seizure rescue medications during the school day, at school-sponsored activities, or while on a school bus or other school property if (i) the student’s parent has submitted a seizure management and action plan in accordance with § 22.1-274.6 that includes written consent of the parent and written approval of the student’s primary care provider for such self-possession and (ii) the school nurse has been notified of such self-possession; or2\n\nFor the administration of seizure rescue medications to any student enrolled in any elementary or secondary school in the local school division who has a diagnosis of a condition causing seizures, consistent with the provisions of subsection BB of § 54.1-3408.","order_by":null,"text":{"0":{"id":280461,"text":"Local school boards shall develop and implement policies permitting a student with a diagnosis of asthma or anaphylaxis, or both, to possess and self-administer inhaled asthma medications or auto-injectable epinephrine, or both, as the case may be, during the school day, at school-sponsored activities, or while on a school bus or other school property. Such policies shall include, but not be limited to, provisions for:","type":"section","prefixes":["A"],"prefix":"A","entire_prefix":"A","prefix_anchor":"A","level":1,"next_prefix":"A1"},"1":{"id":280462,"text":"Written consent of the parent, as defined in § 22.1-1, of a student with a diagnosis of asthma or anaphylaxis, or both, that the student may self-administer inhaled asthma medications or auto-injectable epinephrine, or both, as the case may be.","type":"section","prefixes":["A","1"],"prefix":"1","entire_prefix":"A1","prefix_anchor":"A1","level":2,"prior_prefix":"A","next_prefix":"A2"},"2":{"id":280463,"text":"Written notice from the student’s primary care provider or medical specialist, or a licensed physician or licensed advanced practice registered nurse, that (i) identifies the student; (ii) states that the student has a diagnosis of asthma or anaphylaxis, or both, and has approval to self-administer inhaled asthma medications or auto-injectable epinephrine, or both, as the case may be, that have been prescribed or authorized for the student; (iii) specifies the name and dosage of the medication, the frequency in which it is to be administered and certain circumstances which may warrant the use of inhaled asthma medications or auto-injectable epinephrine, such as before exercising or engaging in physical activity to prevent the onset of asthma symptoms or to alleviate asthma symptoms after the onset of an asthma episode; and (iv) attests to the student’s demonstrated ability to safely and effectively self-administer inhaled asthma medications or auto-injectable epinephrine, or both, as the case may be.","type":"section","prefixes":["A","2"],"prefix":"2","entire_prefix":"A2","prefix_anchor":"A2","level":2,"prior_prefix":"A1","next_prefix":"A3"},"3":{"id":280464,"text":"Development of an individualized health care plan, including emergency procedures for any life-threatening conditions.","type":"section","prefixes":["A","3"],"prefix":"3","entire_prefix":"A3","prefix_anchor":"A3","level":2,"prior_prefix":"A2","next_prefix":"A4"},"4":{"id":280465,"text":"Consultation with the student’s parent before any limitations or restrictions are imposed upon a student’s possession and self-administration of inhaled asthma medications and auto-injectable epinephrine, and before the permission to possess and self-administer inhaled asthma medications and auto-injectable epinephrine at any point during the school year is revoked.","type":"section","prefixes":["A","4"],"prefix":"4","entire_prefix":"A4","prefix_anchor":"A4","level":2,"prior_prefix":"A3","next_prefix":"A5"},"5":{"id":280466,"text":"Self-administration of inhaled asthma medications and auto-injectable epinephrine to be consistent with the purposes of the Virginia School Health Guidelines and the Guidelines for Specialized Health Care Procedure Manuals, which are jointly issued by the Department of Education and the Department of Health.","type":"section","prefixes":["A","5"],"prefix":"5","entire_prefix":"A5","prefix_anchor":"A5","level":2,"prior_prefix":"A4","next_prefix":"A6"},"6":{"id":280467,"text":"Disclosure or dissemination of information pertaining to the health condition of a student to school board employees to comply with §§ 22.1-287 and 22.1-289 and the federal Family Education Rights and Privacy Act of 1974, as amended, 20 U.S.C. § 1232g, which govern the disclosure and dissemination of information contained in student scholastic records.","type":"section","prefixes":["A","6"],"prefix":"6","entire_prefix":"A6","prefix_anchor":"A6","level":2,"prior_prefix":"A5","next_prefix":"B"},"7":{"id":280468,"text":"The permission granted a student with a diagnosis of asthma or anaphylaxis, or both, to possess and self-administer inhaled asthma medications or auto-injectable epinephrine, or both, shall be effective for one school year. Permission to possess and self-administer such medications shall be renewed annually. For the purposes of this section, “one school year” means 365 calendar days.","type":"section","prefixes":["B"],"prefix":"B","entire_prefix":"B","prefix_anchor":"B","level":1,"prior_prefix":"A6","next_prefix":"C"},"8":{"id":280469,"text":"Local school boards shall adopt and implement policies for the possession and administration of epinephrine in every school, to be administered by any school nurse, employee of the school board, employee of a local governing body, or employee of a local health department who is authorized by a prescriber and trained in the administration of epinephrine to any student believed to be having an anaphylactic reaction. Such policies shall require that at least one school nurse, employee of the school board, employee of a local governing body, or employee of a local health department who is authorized by a prescriber and trained in the administration of epinephrine has the means to access at all times during regular school hours any such epinephrine that is stored in a locked or otherwise generally inaccessible container or area.","type":"section","prefixes":["C"],"prefix":"C","entire_prefix":"C","prefix_anchor":"C","level":1,"prior_prefix":"B","next_prefix":"D"},"9":{"id":280470,"text":"Each local school board shall adopt and implement policies for the possession and administration of undesignated stock albuterol inhalers and valved holding chambers in every public school in the local school division, to be administered by any school nurse, licensed athletic trainer under contract with a local school division, employee of the school board, employee of a local governing body, or employee of a local health department who is authorized by the local health director and trained in the administration of albuterol inhalers and valved holding chambers for any student believed in good faith to be in need of such medication.","type":"section","prefixes":["D"],"prefix":"D","entire_prefix":"D","prefix_anchor":"D","level":1,"prior_prefix":"C","next_prefix":"E"},"10":{"id":280471,"text":"Any local school board may adopt and implement policies for the possession and administration of undesignated nasal or injectable glucagon in each public elementary or secondary school in the local school division, provided that such policies are consistent with the guidance outlined in the most recent revision of the Diabetes Management In School: Manual for Unlicensed Personnel published by the Department and include guidance outlining the following:","type":"section","prefixes":["E"],"prefix":"E","entire_prefix":"E","prefix_anchor":"E","level":1,"prior_prefix":"D","next_prefix":"E1"},"11":{"id":280472,"text":"One or more locations in each public elementary or secondary school in the local school division in which doses of such undesignated glucagon shall be stored;","type":"section","prefixes":["E","1"],"prefix":"1","entire_prefix":"E1","prefix_anchor":"E1","level":2,"prior_prefix":"E","next_prefix":"E2"},"12":{"id":280473,"text":"The conditions under which doses of such undesignated glucagon shall be stored, replaced, and disposed;","type":"section","prefixes":["E","2"],"prefix":"2","entire_prefix":"E2","prefix_anchor":"E2","level":2,"prior_prefix":"E1","next_prefix":"E3"},"13":{"id":280474,"text":"The individuals who are authorized to access and administer doses of such undesignated glucagon in an emergency and training requirements for such individuals; and","type":"section","prefixes":["E","3"],"prefix":"3","entire_prefix":"E3","prefix_anchor":"E3","level":2,"prior_prefix":"E2","next_prefix":"E4"},"14":{"id":280475,"text":"A process for requesting emergency medical services and notifying appropriate personnel immediately after a dose of such undesignated glucagon is administered.","type":"section","prefixes":["E","4"],"prefix":"4","entire_prefix":"E4","prefix_anchor":"E4","level":2,"prior_prefix":"E3","next_prefix":"F"},"15":{"id":280476,"text":"Any public elementary or secondary school may maintain a supply of nasal or injectable glucagon in any secure location that is immediately accessible to any school nurse or other employee trained in the administration of nasal and injectable glucagon prescribed to the school by a prescriber, as defined in § 54.1-3401. Any such school shall ensure that such a supply consists of at least two doses. Any school nurse or other authorized employee who is trained in the administration of nasal and injectable glucagon consistent with the guidance outlined in the most recent revision of the Diabetes Management In School: Manual for Unlicensed Personnel published by the Department may administer nasal or injectable glucagon from undesignated inventory with parental consent and if the student’s prescribed glucagon is not available on school grounds or has expired.","type":"section","prefixes":["F"],"prefix":"F","entire_prefix":"F","prefix_anchor":"F","level":1,"prior_prefix":"E4","next_prefix":"G"},"16":{"id":280477,"text":"Any school board may accept donations of nasal or injectable glucagon from a wholesale distributor of glucagon or donations of money from any individual to purchase nasal or injectable glucagon for the purpose of maintenance and administration in a public school in the local school division as permitted pursuant to subsection F.","type":"section","prefixes":["G"],"prefix":"G","entire_prefix":"G","prefix_anchor":"G","level":1,"prior_prefix":"F","next_prefix":"H"},"17":{"id":280478,"text":"Any school board may adopt and implement policies:","type":"section","prefixes":["H"],"prefix":"H","entire_prefix":"H","prefix_anchor":"H","level":1,"prior_prefix":"G","next_prefix":"H1"},"18":{"id":280479,"text":"Permitting any student enrolled in any secondary school in the local school division who has a diagnosis of a condition causing seizures to possess seizure rescue medications during the school day, at school-sponsored activities, or while on a school bus or other school property if (i) the student’s parent has submitted a seizure management and action plan in accordance with § 22.1-274.6 that includes written consent of the parent and written approval of the student’s primary care provider for such self-possession and (ii) the school nurse has been notified of such self-possession; or","type":"section","prefixes":["H","1"],"prefix":"1","entire_prefix":"H1","prefix_anchor":"H1","level":2,"prior_prefix":"H","next_prefix":"H2"},"19":{"id":280480,"text":"For the administration of seizure rescue medications to any student enrolled in any elementary or secondary school in the local school division who has a diagnosis of a condition causing seizures, consistent with the provisions of subsection BB of § 54.1-3408.","type":"section","prefixes":["H","2"],"prefix":"2","entire_prefix":"H2","prefix_anchor":"H2","level":2,"prior_prefix":"H1"}},"ancestry":[{"id":13512,"edition_id":1,"name":"Health Provisions","identifier":"2","label":"article","depth":3,"order_by":1,"parent_id":12850,"metadata":{},"date_created":"2026-06-26 03:45:06","date_modified":"2026-06-26 03:45:06","permalink":{"id":182221,"object_type":"structure","relational_id":13512,"identifier":"2","token":"22.1\/14\/2","url":"\/22.1\/14\/2\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12850,"edition_id":1,"name":"Pupils","identifier":"14","label":"chapter","depth":2,"order_by":1,"parent_id":12823,"metadata":{},"date_created":"2026-06-26 03:43:56","date_modified":"2026-06-26 03:43:56","permalink":{"id":182133,"object_type":"structure","relational_id":12850,"identifier":"14","token":"22.1\/14","url":"\/22.1\/14\/","edition_id":1,"permalink":0,"preferred":1}},{"id":12823,"edition_id":1,"name":"Education","identifier":"22.1","label":"title","depth":1,"order_by":1,"parent_id":null,"metadata":{},"date_created":"2026-06-26 03:43:55","date_modified":"2026-06-26 03:43:55","permalink":{"id":180949,"object_type":"structure","relational_id":12823,"identifier":"22.1","token":"22.1","url":"\/22.1\/","edition_id":1,"permalink":0,"preferred":1}}],"structure_contents":[{"id":83399,"structure_id":13512,"section_number":"22.1-270","catch_line":"Preschool physical examinations","url":"\/22.1-270\/","token":"22.1\/14\/2\/22.1-270","metadata":false},{"id":57306,"structure_id":13512,"section_number":"22.1-271","catch_line":"Repealed","url":"\/22.1-271\/","token":"22.1\/14\/2\/22.1-271","metadata":false},{"id":68537,"structure_id":13512,"section_number":"22.1-271.1","catch_line":"Definitions","url":"\/22.1-271.1\/","token":"22.1\/14\/2\/22.1-271.1","metadata":false},{"id":54801,"structure_id":13512,"section_number":"22.1-271.10","catch_line":"Guidelines and policies on student-athlete extreme heat safety and protection","url":"\/22.1-271.10\/","token":"22.1\/14\/2\/22.1-271.10","metadata":false},{"id":68882,"structure_id":13512,"section_number":"22.1-271.2","catch_line":"Immunization requirements","url":"\/22.1-271.2\/","token":"22.1\/14\/2\/22.1-271.2","metadata":false},{"id":80851,"structure_id":13512,"section_number":"22.1-271.3","catch_line":"Guidelines for school attendance for children infected with human immunodeficiency virus; school personnel training required; notification of school personnel in certain cases","url":"\/22.1-271.3\/","token":"22.1\/14\/2\/22.1-271.3","metadata":false},{"id":58904,"structure_id":13512,"section_number":"22.1-271.4","catch_line":"Health requirements for home-instructed, exempted, and excused children","url":"\/22.1-271.4\/","token":"22.1\/14\/2\/22.1-271.4","metadata":false},{"id":58468,"structure_id":13512,"section_number":"22.1-271.5","catch_line":"Guidelines and policies and procedures on concussions in student-athletes","url":"\/22.1-271.5\/","token":"22.1\/14\/2\/22.1-271.5","metadata":false},{"id":62863,"structure_id":13512,"section_number":"22.1-271.6","catch_line":"School division policies and procedures on concussions in students","url":"\/22.1-271.6\/","token":"22.1\/14\/2\/22.1-271.6","metadata":false},{"id":74380,"structure_id":13512,"section_number":"22.1-271.7","catch_line":"Public middle and high school student-athletes; pre-participation physical examination","url":"\/22.1-271.7\/","token":"22.1\/14\/2\/22.1-271.7","metadata":false},{"id":64618,"structure_id":13512,"section_number":"22.1-271.8","catch_line":"Sudden cardiac arrest prevention in student-athletes","url":"\/22.1-271.8\/","token":"22.1\/14\/2\/22.1-271.8","metadata":false},{"id":61392,"structure_id":13512,"section_number":"22.1-271.9","catch_line":"Cardiac emergency response or emergency action plans required","url":"\/22.1-271.9\/","token":"22.1\/14\/2\/22.1-271.9","metadata":false},{"id":60318,"structure_id":13512,"section_number":"22.1-272","catch_line":"Contagious and infectious diseases","url":"\/22.1-272\/","token":"22.1\/14\/2\/22.1-272","metadata":false},{"id":63093,"structure_id":13512,"section_number":"22.1-272.1","catch_line":"Responsibility to contact parent of student at imminent risk of suicide; notice to be given to social services if parental abuse or neglect; Board of Education to develop guidelines for parental contact","url":"\/22.1-272.1\/","token":"22.1\/14\/2\/22.1-272.1","metadata":false},{"id":64351,"structure_id":13512,"section_number":"22.1-272.1:1","catch_line":"School-connected student overdose policies; parental notification; guidelines","url":"\/22.1-272.1_1\/","token":"22.1\/14\/2\/22.1-272.1_1","metadata":false},{"id":84018,"structure_id":13512,"section_number":"22.1-272.2","catch_line":"Department; model memorandum of understanding; partnerships with community mental health services providers or a nationally recognized school-based telehealth provider","url":"\/22.1-272.2\/","token":"22.1\/14\/2\/22.1-272.2","metadata":false},{"id":73957,"structure_id":13512,"section_number":"22.1-272.3","catch_line":"Student access to telehealth services; school division policies","url":"\/22.1-272.3\/","token":"22.1\/14\/2\/22.1-272.3","metadata":false},{"id":68681,"structure_id":13512,"section_number":"22.1-273","catch_line":"Vision and hearing of student to be tested; exceptions","url":"\/22.1-273\/","token":"22.1\/14\/2\/22.1-273","metadata":false},{"id":82468,"structure_id":13512,"section_number":"22.1-273.1","catch_line":"Annual screening for scoliosis","url":"\/22.1-273.1\/","token":"22.1\/14\/2\/22.1-273.1","metadata":false},{"id":80414,"structure_id":13512,"section_number":"22.1-273.2","catch_line":"Parent educational information regarding eating disorders","url":"\/22.1-273.2\/","token":"22.1\/14\/2\/22.1-273.2","metadata":false},{"id":66325,"structure_id":13512,"section_number":"22.1-273.3","catch_line":"Parent educational information regarding tobacco and nicotine vapor products","url":"\/22.1-273.3\/","token":"22.1\/14\/2\/22.1-273.3","metadata":false},{"id":54479,"structure_id":13512,"section_number":"22.1-273.4","catch_line":"Department of Education; guidance and resources; applied behavior analysis services","url":"\/22.1-273.4\/","token":"22.1\/14\/2\/22.1-273.4","metadata":false},{"id":82301,"structure_id":13512,"section_number":"22.1-274","catch_line":"School health services","url":"\/22.1-274\/","token":"22.1\/14\/2\/22.1-274","metadata":false},{"id":87246,"structure_id":13512,"section_number":"22.1-274.01","catch_line":"Repealed","url":"\/22.1-274.01\/","token":"22.1\/14\/2\/22.1-274.01","metadata":false},{"id":62165,"structure_id":13512,"section_number":"22.1-274.01:1","catch_line":"Students who are diagnosed with diabetes; self-care; insertion and reinsertion of insulin pump","url":"\/22.1-274.01_1\/","token":"22.1\/14\/2\/22.1-274.01_1","metadata":false},{"id":62800,"structure_id":13512,"section_number":"22.1-274.02","catch_line":"Certain memorandum of agreement required","url":"\/22.1-274.02\/","token":"22.1\/14\/2\/22.1-274.02","metadata":false},{"id":61298,"structure_id":13512,"section_number":"22.1-274.1","catch_line":"Criteria to identify toxic art materials; labeling; use in certain grades prohibited","url":"\/22.1-274.1\/","token":"22.1\/14\/2\/22.1-274.1","metadata":false},{"id":78246,"structure_id":13512,"section_number":"22.1-274.2","catch_line":"Possession and administration of inhaled asthma medications, epinephrine, glucagon, and seizure rescue medications by certain students or school board employees","url":"\/22.1-274.2\/","token":"22.1\/14\/2\/22.1-274.2","metadata":false},{"id":55245,"structure_id":13512,"section_number":"22.1-274.2:1","catch_line":"Grade nine and grade 10 health education Standards of Learning; severe allergic reaction awareness training","url":"\/22.1-274.2_1\/","token":"22.1\/14\/2\/22.1-274.2_1","metadata":false},{"id":80659,"structure_id":13512,"section_number":"22.1-274.3","catch_line":"Policies regarding medication recommendations by school personnel","url":"\/22.1-274.3\/","token":"22.1\/14\/2\/22.1-274.3","metadata":false},{"id":56415,"structure_id":13512,"section_number":"22.1-274.4","catch_line":"Public elementary and secondary schools; automated external defibrillators required","url":"\/22.1-274.4\/","token":"22.1\/14\/2\/22.1-274.4","metadata":false},{"id":81947,"structure_id":13512,"section_number":"22.1-274.4:1","catch_line":"Opioid antagonist procurement, placement, maintenance, and administration; staff and faculty training; policies and requirements","url":"\/22.1-274.4_1\/","token":"22.1\/14\/2\/22.1-274.4_1","metadata":false},{"id":74919,"structure_id":13512,"section_number":"22.1-274.5","catch_line":"Topical sunscreen","url":"\/22.1-274.5\/","token":"22.1\/14\/2\/22.1-274.5","metadata":false},{"id":78903,"structure_id":13512,"section_number":"22.1-274.6","catch_line":"Seizure management and action plan; training","url":"\/22.1-274.6\/","token":"22.1\/14\/2\/22.1-274.6","metadata":false},{"id":73551,"structure_id":13512,"section_number":"22.1-274.7","catch_line":"Students with disabilities; individualized education programs; individualized accommodations and supports during emergency situations and evacuations","url":"\/22.1-274.7\/","token":"22.1\/14\/2\/22.1-274.7","metadata":false},{"id":70375,"structure_id":13512,"section_number":"22.1-274.8","catch_line":"School boards; bleeding control programs; bleeding control kits","url":"\/22.1-274.8\/","token":"22.1\/14\/2\/22.1-274.8","metadata":false},{"id":79734,"structure_id":13512,"section_number":"22.1-275","catch_line":"Protective eye devices","url":"\/22.1-275\/","token":"22.1\/14\/2\/22.1-275","metadata":false},{"id":81726,"structure_id":13512,"section_number":"22.1-275.1","catch_line":"School health advisory board","url":"\/22.1-275.1\/","token":"22.1\/14\/2\/22.1-275.1","metadata":false}],"previous_section":{"id":61298,"structure_id":13512,"section_number":"22.1-274.1","catch_line":"Criteria to identify toxic art materials; labeling; use in certain grades prohibited","url":"\/22.1-274.1\/","token":"22.1\/14\/2\/22.1-274.1","metadata":false},"next_section":{"id":55245,"structure_id":13512,"section_number":"22.1-274.2:1","catch_line":"Grade nine and grade 10 health education Standards of Learning; severe allergic reaction awareness training","url":"\/22.1-274.2_1\/","token":"22.1\/14\/2\/22.1-274.2_1","metadata":false},"metadata":false,"official_url":"https:\/\/law.lis.virginia.gov\/vacode\/22.1-274.2\/","history_text":"

This law was first created in 2000. The record of its establishment is cataloged in chapter 871<\/a> of that year\u2019s edition of \u201cActs of Assembly,\u201d the annual state publication listing all changes made to the Code of Virginia in that year. It has been modified 7 times. Those modifications are cataloged by \u201cThe Acts of Assembly,\u201d a state publication, by year and chapter. Those modifications that can be read on the General Assembly\u2019s website will be linked accordingly. Those modifications are as follows: in 2005, chapter 785<\/a>; in 2012, chapters 787<\/a> and 833<\/a>; in 2013, chapters 336<\/a> and 617<\/a>; in 2020, chapter 476<\/a>; in 2023, chapters 183<\/a> and 569<\/a>; in 2024, chapter 466<\/a>; in 2025, chapters 59<\/a> and 65<\/a>.<\/p>","references":[{"id":78903,"section_number":"22.1-274.6","catch_line":"Seizure management and action plan; training","order_by":null,"url":"\/22.1-274.6\/"},{"id":77665,"section_number":"54.1-3408","catch_line":"Professional use by practitioners","order_by":null,"url":"\/54.1-3408\/"},{"id":64301,"section_number":"8.01-226.5:1","catch_line":"Civil immunity for school board employees supervising self-administration of certain medication","order_by":null,"url":"\/8.01-226.5_1\/"}],"refers_to":[{"id":74111,"section_number":"22.1-1","catch_line":"(Effective July 1, 2026) Definitions","order_by":null,"url":"\/22.1-1\/"},{"id":78903,"section_number":"22.1-274.6","catch_line":"Seizure management and action plan; training","order_by":null,"url":"\/22.1-274.6\/"},{"id":86899,"section_number":"22.1-287","catch_line":"Limitations on access to records","order_by":null,"url":"\/22.1-287\/"},{"id":80543,"section_number":"22.1-289","catch_line":"Transfer and management of scholastic records; disclosure of information in court notices; penalty","order_by":null,"url":"\/22.1-289\/"},{"id":59669,"section_number":"54.1-3401","catch_line":"Definitions","order_by":null,"url":"\/54.1-3401\/"},{"id":77665,"section_number":"54.1-3408","catch_line":"Professional use by practitioners","order_by":null,"url":"\/54.1-3408\/"}],"permalink":{"id":182331,"object_type":"law","relational_id":78246,"identifier":"22.1-274.2","token":"22.1\/14\/2\/22.1-274.2","url":"\/22.1-274.2\/","edition_id":1,"permalink":0,"preferred":1},"url":"\/22.1-274.2\/","token":"22.1\/14\/2\/22.1-274.2","dublin_core":{"Title":"Possession and administration of inhaled asthma medications, epinephrine, glucagon, and seizure rescue medications by certain students or school board employees","Type":"Text","Format":"text\/html","Identifier":"\u00a7 22.1-274.2","Relation":"Code of Virginia"},"html":"\n\t\t\t\t\t\t

A.<\/span> Local school boards<\/span> shall develop and implement policies permitting a student with a diagnosis of asthma or anaphylaxis, or both, to possess and self-administer inhaled asthma medications or auto-injectable epinephrine, or both, as the case may be, during the school day, at school-sponsored activities, or while on a school bus or other school property. Such policies shall include, but not be limited to, provisions for: <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

1.<\/span> Written consent of the parent<\/span>, as defined in § 22.1-1<\/a>, of a student with a diagnosis of asthma or anaphylaxis, or both, that the student may self-administer inhaled asthma medications or auto-injectable epinephrine, or both, as the case may be. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

2.<\/span> Written notice from the student’s primary care provider or medical specialist, or a licensed physician or licensed advanced practice registered nurse, that (i) identifies the student; (ii) states that the student has a diagnosis of asthma or anaphylaxis, or both, and has approval to self-administer inhaled asthma medications or auto-injectable epinephrine, or both, as the case may be, that have been prescribed or authorized for the student; (iii) specifies the name and dosage of the medication, the frequency in which it is to be administered and certain circumstances which may warrant the use of inhaled asthma medications or auto-injectable epinephrine, such as before exercising or engaging in physical activity to prevent the onset of asthma symptoms or to alleviate asthma symptoms after the onset of an asthma episode; and (iv) attests to the student’s demonstrated ability to safely and effectively self-administer inhaled asthma medications or auto-injectable epinephrine, or both, as the case may be. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

3.<\/span> Development of an individualized health care plan, including emergency procedures for any life-threatening conditions. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

4.<\/span> Consultation with the student’s parent<\/span> before any limitations or restrictions are imposed upon a student’s possession<\/span> and self-administration of inhaled asthma medications and auto-injectable epinephrine, and before the permission to possess and self-administer inhaled asthma medications and auto-injectable epinephrine at any point during the school year is revoked. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

5.<\/span> Self-administration of inhaled asthma medications and auto-injectable epinephrine to be consistent with the purposes of the Virginia School Health Guidelines and the Guidelines for Specialized Health Care Procedure Manuals, which are jointly issued by the Department<\/span> of Education and the Department<\/span> of Health. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

6.<\/span> Disclosure or dissemination of information pertaining to the health condition of a student to school board<\/span> employees to comply with §§ 22.1-287<\/a> and 22.1-289<\/a> and the federal Family Education Rights and Privacy Act of 1974, as amended, 20 U.S.C. § 1232g, which govern the disclosure and dissemination of information contained in student scholastic records. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

B.<\/span> The permission granted a student with a diagnosis of asthma or anaphylaxis, or both, to possess and self-administer inhaled asthma medications or auto-injectable epinephrine, or both, shall be effective for one school year<\/span>. Permission to possess and self-administer such medications shall be renewed annually. For the purposes of this section, “one school year<\/span>” means 365 calendar days. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

C.<\/span> Local school boards<\/span> shall adopt and implement policies for the possession<\/span> and administration of epinephrine in every school, to be administered by any school nurse, employee of the school board<\/span>, employee of a local governing body<\/span>, or employee of a local health department<\/span> who is authorized by a prescriber and trained in the administration of epinephrine to any student believed to be having an anaphylactic reaction. Such policies shall require that at least one school nurse, employee of the school board<\/span>, employee of a local governing body<\/span>, or employee of a local health department<\/span> who is authorized by a prescriber and trained in the administration of epinephrine has the means to access at all times during regular school hours any such epinephrine that is stored in a locked or otherwise generally inaccessible container or area. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

D.<\/span> Each local school board<\/span> shall adopt and implement policies for the possession<\/span> and administration of undesignated stock albuterol inhalers and valved holding chambers<\/span> in every public school in the local school division, to be administered by any school nurse, licensed athletic trainer under contract<\/span> with a local school division, employee of the school board<\/span>, employee of a local governing body<\/span>, or employee of a local health department<\/span> who is authorized by the local health director and trained in the administration of albuterol inhalers and valved holding chambers<\/span> for any student believed in good faith to be in need of such medication. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

E.<\/span> Any local school board<\/span> may adopt and implement policies for the possession<\/span> and administration of undesignated nasal or injectable glucagon in each public elementary<\/span> or secondary school in the local school division, provided that such policies are consistent with the guidance outlined in the most recent revision of the Diabetes Management In School: Manual for Unlicensed Personnel published by the Department<\/span> and include guidance outlining the following: <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

1.<\/span> One or more locations in each public elementary<\/span> or secondary school in the local school division in which doses of such undesignated glucagon shall be stored; <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

2.<\/span> The conditions under which doses of such undesignated glucagon shall be stored, replaced, and disposed; <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

3.<\/span> The individuals who are authorized to access and administer doses of such undesignated glucagon in an emergency and training requirements for such individuals; and <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

4.<\/span> A process for requesting emergency medical services and notifying appropriate personnel immediately after a dose of such undesignated glucagon is administered. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

F.<\/span> Any public elementary<\/span> or secondary school may maintain a supply of nasal or injectable glucagon in any secure location that is immediately accessible to any school nurse or other employee trained in the administration of nasal and injectable glucagon prescribed to the school by a prescriber, as defined in § 54.1-3401<\/a>. Any such school shall ensure that such a supply consists of at least two doses. Any school nurse or other authorized employee who is trained in the administration of nasal and injectable glucagon consistent with the guidance outlined in the most recent revision of the Diabetes Management In School: Manual for Unlicensed Personnel published by the Department<\/span> may administer nasal or injectable glucagon from undesignated inventory with parental consent and if the student’s prescribed glucagon is not available on school grounds or has expired. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

G.<\/span> Any school board<\/span> may accept donations of nasal or injectable glucagon from a wholesale distributor of glucagon or donations of money from any individual to purchase nasal or injectable glucagon for the purpose of maintenance and administration in a public school in the local school division as permitted pursuant to subsection F. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

H.<\/span> Any school board<\/span> may adopt and implement policies: <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

1.<\/span> Permitting any student enrolled in any secondary school in the local school division who has a diagnosis of a condition causing seizures to possess seizure rescue medications during the school day, at school-sponsored activities, or while on a school bus or other school property if (i) the student’s parent<\/span> has submitted a seizure management and action plan in accordance with § 22.1-274.6<\/a> that includes written consent of the parent<\/span> and written approval of the student’s primary care provider for such self-possession<\/span> and (ii) the school nurse has been notified of such self-possession<\/span>; or <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

2.<\/span> For the administration of seizure rescue medications to any student enrolled in any elementary<\/span> or secondary school in the local school division who has a diagnosis of a condition causing seizures, consistent with the provisions of subsection BB of § 54.1-3408<\/a>. <\/i><\/a><\/p><\/section>","plain_text":" CODE OF VIRGINIA\n\nPOSSESSION AND ADMINISTRATION OF INHALED ASTHMA MEDICATIONS, EPINEPHRINE,\nGLUCAGON, AND SEIZURE RESCUE MEDICATIONS BY CERTAIN STUDENTS OR SCHOOL BOARD\nEMPLOYEES (\u00a7 22.1-274.2)\n\nA. Local school boards shall develop and implement policies permitting a student\nwith a diagnosis of asthma or anaphylaxis, or both, to possess and\nself-administer inhaled asthma medications or auto-injectable epinephrine, or\nboth, as the case may be, during the school day, at school-sponsored activities,\nor while on a school bus or other school property. Such policies shall include,\nbut not be limited to, provisions for:\n\n 1. Written consent of the parent, as defined in § 22.1-1, of a student\n with a diagnosis of asthma or anaphylaxis, or both, that the student may\n self-administer inhaled asthma medications or auto-injectable epinephrine, or\n both, as the case may be.\n\n 2. Written notice from the student’s primary care provider or medical\n specialist, or a licensed physician or licensed advanced practice registered\n nurse, that (i) identifies the student; (ii) states that the student has a\n diagnosis of asthma or anaphylaxis, or both, and has approval to\n self-administer inhaled asthma medications or auto-injectable epinephrine, or\n both, as the case may be, that have been prescribed or authorized for the\n student; (iii) specifies the name and dosage of the medication, the frequency\n in which it is to be administered and certain circumstances which may warrant\n the use of inhaled asthma medications or auto-injectable epinephrine, such as\n before exercising or engaging in physical activity to prevent the onset of\n asthma symptoms or to alleviate asthma symptoms after the onset of an asthma\n episode; and (iv) attests to the student’s demonstrated ability to\n safely and effectively self-administer inhaled asthma medications or\n auto-injectable epinephrine, or both, as the case may be.\n\n 3. Development of an individualized health care plan, including emergency\n procedures for any life-threatening conditions.\n\n 4. Consultation with the student’s parent before any limitations or\n restrictions are imposed upon a student’s possession and\n self-administration of inhaled asthma medications and auto-injectable\n epinephrine, and before the permission to possess and self-administer inhaled\n asthma medications and auto-injectable epinephrine at any point during the\n school year is revoked.\n\n 5. Self-administration of inhaled asthma medications and auto-injectable\n epinephrine to be consistent with the purposes of the Virginia School Health\n Guidelines and the Guidelines for Specialized Health Care Procedure Manuals,\n which are jointly issued by the Department of Education and the Department of\n Health.\n\n 6. Disclosure or dissemination of information pertaining to the health\n condition of a student to school board employees to comply with §§\n 22.1-287 and 22.1-289 and the federal Family Education Rights and Privacy Act\n of 1974, as amended, 20 U.S.C. § 1232g, which govern the disclosure and\n dissemination of information contained in student scholastic records.\n\nB. The permission granted a student with a diagnosis of asthma or anaphylaxis,\nor both, to possess and self-administer inhaled asthma medications or\nauto-injectable epinephrine, or both, shall be effective for one school year.\nPermission to possess and self-administer such medications shall be renewed\nannually. For the purposes of this section, “one school year” means\n365 calendar days.\n\nC. Local school boards shall adopt and implement policies for the possession and\nadministration of epinephrine in every school, to be administered by any school\nnurse, employee of the school board, employee of a local governing body, or\nemployee of a local health department who is authorized by a prescriber and\ntrained in the administration of epinephrine to any student believed to be\nhaving an anaphylactic reaction. Such policies shall require that at least one\nschool nurse, employee of the school board, employee of a local governing body,\nor employee of a local health department who is authorized by a prescriber and\ntrained in the administration of epinephrine has the means to access at all\ntimes during regular school hours any such epinephrine that is stored in a\nlocked or otherwise generally inaccessible container or area.\n\nD. Each local school board shall adopt and implement policies for the possession\nand administration of undesignated stock albuterol inhalers and valved holding\nchambers in every public school in the local school division, to be administered\nby any school nurse, licensed athletic trainer under contract with a local\nschool division, employee of the school board, employee of a local governing\nbody, or employee of a local health department who is authorized by the local\nhealth director and trained in the administration of albuterol inhalers and\nvalved holding chambers for any student believed in good faith to be in need of\nsuch medication.\n\nE. Any local school board may adopt and implement policies for the possession\nand administration of undesignated nasal or injectable glucagon in each public\nelementary or secondary school in the local school division, provided that such\npolicies are consistent with the guidance outlined in the most recent revision\nof the Diabetes Management In School: Manual for Unlicensed Personnel published\nby the Department and include guidance outlining the following:\n\n 1. One or more locations in each public elementary or secondary school in the\n local school division in which doses of such undesignated glucagon shall be\n stored;\n\n 2. The conditions under which doses of such undesignated glucagon shall be\n stored, replaced, and disposed;\n\n 3. The individuals who are authorized to access and administer doses of such\n undesignated glucagon in an emergency and training requirements for such\n individuals; and\n\n 4. A process for requesting emergency medical services and notifying\n appropriate personnel immediately after a dose of such undesignated glucagon\n is administered.\n\nF. Any public elementary or secondary school may maintain a supply of nasal or\ninjectable glucagon in any secure location that is immediately accessible to any\nschool nurse or other employee trained in the administration of nasal and\ninjectable glucagon prescribed to the school by a prescriber, as defined in\n§ 54.1-3401. Any such school shall ensure that such a supply consists of at\nleast two doses. Any school nurse or other authorized employee who is trained in\nthe administration of nasal and injectable glucagon consistent with the guidance\noutlined in the most recent revision of the Diabetes Management In School:\nManual for Unlicensed Personnel published by the Department may administer nasal\nor injectable glucagon from undesignated inventory with parental consent and if\nthe student’s prescribed glucagon is not available on school grounds or\nhas expired.\n\nG. Any school board may accept donations of nasal or injectable glucagon from a\nwholesale distributor of glucagon or donations of money from any individual to\npurchase nasal or injectable glucagon for the purpose of maintenance and\nadministration in a public school in the local school division as permitted\npursuant to subsection F.\n\nH. Any school board may adopt and implement policies:\n\n 1. Permitting any student enrolled in any secondary school in the local school\n division who has a diagnosis of a condition causing seizures to possess\n seizure rescue medications during the school day, at school-sponsored\n activities, or while on a school bus or other school property if (i) the\n student’s parent has submitted a seizure management and action plan in\n accordance with § 22.1-274.6 that includes written consent of the parent\n and written approval of the student’s primary care provider for such\n self-possession and (ii) the school nurse has been notified of such\n self-possession; or\n\n 2. For the administration of seizure rescue medications to any student\n enrolled in any elementary or secondary school in the local school division\n who has a diagnosis of a condition causing seizures, consistent with the\n provisions of subsection BB of § 54.1-3408.\n\nHISTORY: 2000, c. 871; 2005, c. 785; 2012, cc. 787, 833; 2013, cc. 336, 617;\n2020, c. 476; 2021, Sp. Sess. I, c. 508; 2023, cc. 183, 569; 2024, c. 466; 2025,\ncc. 59, 65.","edition":{"id":1,"name":"2025","slug":"2025","date_created":"2026-06-21 22:39:22","date_modified":"2026-06-21 22:39:22","current":1,"order_by":1,"last_import":null}}